CD163 and neoplasm: When examining CD163 expression by tumor locations, Fortis et al. found that disease-free survival (DFS) and OS were prolonged in patients with CD163 expression that was low in the tumor center but high at the invasive margins compared to the inverse (i.e., high in tumor center and low in the invasive margin) [32].